Bolt Biotherapeutics CEO William P. Quinn buys 637 shares
Bolt Biotherapeutics Inc. President, Chief Executive Officer, Chief Financial Officer and director William P. Quinn bought 637 common shares at $3.88, increasing his holdings to 2,950 shares before later selling 17,566 shares at weighted average prices of $3.77, $3.32 and $3.24.